Sep 3, 2026 08:00AM
Sep 1, 2026 08:03AM
Jul 30, 2026 08:02AM
Jul 10, 2026 08:02AM
Jul 10, 2026 08:00AM
Jul 6, 2026 09:00AM
Jun 25, 2026 08:15AM Mira Pharmaceuticals reports new preclinical data on Mira-55
Jun 25, 2026 08:15AM
Jun 17, 2026 08:00AM
Jun 17, 2026 08:00AM
Jun 4, 2026 08:02AM
Jun 4, 2026 08:00AM
May 27, 2026 08:00AM
May 27, 2026 08:00AM MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
May 14, 2026 08:01AM
May 14, 2026 08:00AM
May 13, 2026 08:04AM
May 13, 2026 08:00AM
Mar 23, 2026 09:03AM
Mar 23, 2026 09:00AM
Mar 4, 2026 08:00AM MIRA Pharmaceuticals completes phase 1 trial for oral pain drug
Mar 4, 2026 08:00AM
Feb 3, 2026 07:31AM
Feb 3, 2026 07:30AM
Oct 24, 2025 07:30AM
Oct 24, 2025 07:30AM
Oct 16, 2025 04:05PM
Oct 16, 2025 07:30AM MIRA Pharmaceuticals reports oral Mira-55 outperformed morphine in pain study
Oct 16, 2025 07:30AM
Sep 30, 2025 07:31AM
Sep 30, 2025 07:30AM
Sep 22, 2025 08:02AM
Sep 22, 2025 08:00AM
Sep 16, 2025 07:30AM
Sep 16, 2025 07:30AM MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
Sep 15, 2025 04:06PM
Sep 12, 2025 07:30AM
Sep 12, 2025 07:30AM
Aug 19, 2025 08:30AM
Aug 19, 2025 08:30AM
Aug 12, 2025 08:32AM
Aug 12, 2025 08:30AM MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabal
Jul 30, 2025 07:30AM
Jul 30, 2025 07:30AM
Jul 29, 2025 07:31AM
Jul 29, 2025 07:30AM
Jul 11, 2025 08:00AM
Jul 11, 2025 08:00AM
Jul 3, 2025 08:02AM Mira Pharma (MIRA) Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks
Jul 3, 2025 08:00AM

461,071 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All